Apidemia IVS: Financial statements 2016
CVR: 37503312
Source: annual report 2016, Danish Business Authority
01/03/2016 – 31/12/2016
Apidemia IVS (CVR 37503312) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -104,785 and a net result of DKK -261,932. Equity in the 2016 report amounted to DKK -261,931. The company had 1 employee in the financial year.
- Gross Profit
- DKK -104,785
- Profit/Loss
- DKK -261,932
- Equity
- DKK -261,931
- Total Assets
- DKK 47,097
- Employees
- 1
Official annual report
Find more companies like Apidemia IVS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
On March 2, 2016, the company changed its name from dotboost IVS to Apidemia IVS.
As of March 1, 2016, Mara-Elena Somesan-Tarau is registered as director of Apidemia IVS.
Apidemia IVS was founded on March 1, 2016.
About Apidemia IVS
Apidemia IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 10 November 2022. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company was previously named dotboost IVS. The company has 2 employees (2021). In 2020, the company reported a gross profit of DKK 161,017 and a net result of DKK -201,443 compared with DKK 59,896 the year before. Equity in the 2020 report amounted to DKK -1,142,472.